CytomX Therapeutics, Inc. - FORM S-1 - EX-23.1 - August 28, 2015

Attached files

file filename
S-1 - FORM S-1 - CytomX Therapeutics, Inc.d948537ds1.htm
EX-4.4 - EX-4.4 - CytomX Therapeutics, Inc.d948537dex44.htm
EX-4.3 - EX-4.3 - CytomX Therapeutics, Inc.d948537dex43.htm
EX-4.2 - EX-4.2 - CytomX Therapeutics, Inc.d948537dex42.htm
EX-4.5 - EX-4.5 - CytomX Therapeutics, Inc.d948537dex45.htm
EX-3.2 - EX-3.2 - CytomX Therapeutics, Inc.d948537dex32.htm
EX-3.1 - EX-3.1 - CytomX Therapeutics, Inc.d948537dex31.htm
EX-10.7 - EX-10.7 - CytomX Therapeutics, Inc.d948537dex107.htm
EX-10.2 - EX-10.2 - CytomX Therapeutics, Inc.d948537dex102.htm
EX-10.1 - EX-10.1 - CytomX Therapeutics, Inc.d948537dex101.htm
EX-10.4 - EX-10.4 - CytomX Therapeutics, Inc.d948537dex104.htm
EX-10.9 - EX-10.9 - CytomX Therapeutics, Inc.d948537dex109.htm
EX-10.3 - EX-10.3 - CytomX Therapeutics, Inc.d948537dex103.htm
EX-10.8 - EX-10.8 - CytomX Therapeutics, Inc.d948537dex108.htm
EX-10.23 - EX-10.23 - CytomX Therapeutics, Inc.d948537dex1023.htm
EX-10.13 - EX-10.13 - CytomX Therapeutics, Inc.d948537dex1013.htm
EX-10.10 - EX-10.10 - CytomX Therapeutics, Inc.d948537dex1010.htm
EX-10.15 - EX-10.15 - CytomX Therapeutics, Inc.d948537dex1015.htm
EX-10.16 - EX-10.16 - CytomX Therapeutics, Inc.d948537dex1016.htm
EX-10.11 - EX-10.11 - CytomX Therapeutics, Inc.d948537dex1011.htm
EX-10.20 - EX-10.20 - CytomX Therapeutics, Inc.d948537dex1020.htm
EX-10.17 - EX-10.17 - CytomX Therapeutics, Inc.d948537dex1017.htm
EX-10.14 - EX-10.14 - CytomX Therapeutics, Inc.d948537dex1014.htm
EX-10.18 - EX-10.18 - CytomX Therapeutics, Inc.d948537dex1018.htm
EX-10.22 - EX-10.22 - CytomX Therapeutics, Inc.d948537dex1022.htm
EX-10.12 - EX-10.12 - CytomX Therapeutics, Inc.d948537dex1012.htm
EX-10.19 - EX-10.19 - CytomX Therapeutics, Inc.d948537dex1019.htm
EX-10.21 - EX-10.21 - CytomX Therapeutics, Inc.d948537dex1021.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We hereby consent to the use in this Registration Statement on Form S-1 of CytomX Therapeutics, Inc. of our report dated July 24, 2015 relating to the financial statements, which appears in such Registration Statement. We also consent to the reference to us under the heading “Experts” in such Registration Statement.

/s/ PricewaterhouseCoopers LLP

San Jose, California

August 28, 2015

CytomX Therapeutics, Inc. Reports